149 related articles for article (PubMed ID: 11948968)
1. Inhibitors of apoptosis proteins in prostate cancer cell lines.
McEleny KR; Watson RW; Coffey RN; O'Neill AJ; Fitzpatrick JM
Prostate; 2002 May; 51(2):133-40. PubMed ID: 11948968
[TBL] [Abstract][Full Text] [Related]
2. An antisense oligonucleotide to cIAP-1 sensitizes prostate cancer cells to fas and TNFalpha mediated apoptosis.
McEleny K; Coffey R; Morrissey C; Williamson K; Zangemeister-Wittke U; Fitzpatrick JM; Watson RW
Prostate; 2004 Jun; 59(4):419-25. PubMed ID: 15065090
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of inhibitor of apoptosis proteins in prostate cancer.
Krajewska M; Krajewski S; Banares S; Huang X; Turner B; Bubendorf L; Kallioniemi OP; Shabaik A; Vitiello A; Peehl D; Gao GJ; Reed JC
Clin Cancer Res; 2003 Oct; 9(13):4914-25. PubMed ID: 14581366
[TBL] [Abstract][Full Text] [Related]
4. Expression of clusterin, XIAP and survivin, and their changes by camptothecin (CPT) treatment in CPT-resistant PC-3 and CPT-sensitive LNCaP cells.
Mizutani K; Matsumoto K; Hasegawa N; Deguchi T; Nozawa Y
Exp Oncol; 2006 Sep; 28(3):209-15. PubMed ID: 17080014
[TBL] [Abstract][Full Text] [Related]
5. The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma.
Azuhata T; Scott D; Takamizawa S; Wen J; Davidoff A; Fukuzawa M; Sandler A
J Pediatr Surg; 2001 Dec; 36(12):1785-91. PubMed ID: 11733907
[TBL] [Abstract][Full Text] [Related]
6. Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma.
Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Edenfield HR; Glickman JN; Yeap BY; Sugarbaker DJ; Bueno R
J Pathol; 2007 Mar; 211(4):447-54. PubMed ID: 17253596
[TBL] [Abstract][Full Text] [Related]
7. The loss of IAP expression during HL-60 cell differentiation is caspase-independent.
Doyle BT; O'Neill AJ; Newsholme P; Fitzpatrick JM; Watson RW
J Leukoc Biol; 2002 Feb; 71(2):247-54. PubMed ID: 11818445
[TBL] [Abstract][Full Text] [Related]
8. Survivin mediates resistance to antiandrogen therapy in prostate cancer.
Zhang M; Latham DE; Delaney MA; Chakravarti A
Oncogene; 2005 Apr; 24(15):2474-82. PubMed ID: 15735703
[TBL] [Abstract][Full Text] [Related]
9. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance.
Ng CP; Zisman A; Bonavida B
Prostate; 2002 Dec; 53(4):286-99. PubMed ID: 12430140
[TBL] [Abstract][Full Text] [Related]
10. Targeting apoptosis in prostate cancer: focus on caspases and inhibitors of apoptosis proteins.
Watson RW; Fitzpatrick JM
BJU Int; 2005 Dec; 96 Suppl 2():30-4. PubMed ID: 16359436
[TBL] [Abstract][Full Text] [Related]
11. Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death.
Yamaguchi Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Saitou Y; Sugimoto K; Nakano T
Oncol Rep; 2005 Nov; 14(5):1311-6. PubMed ID: 16211302
[TBL] [Abstract][Full Text] [Related]
12. Effects of the dual 5 alpha-reductase inhibitor dutasteride on apoptosis in primary cultures of prostate cancer epithelial cells and cell lines.
Maria McCrohan A; Morrissey C; O'Keane C; Mulligan N; Watson C; Smith J; Fitzpatrick JM; Watson RW
Cancer; 2006 Jun; 106(12):2743-52. PubMed ID: 16703599
[TBL] [Abstract][Full Text] [Related]
13. Caffeic acid phenethyl ester-induced PC-3 cell apoptosis is caspase-dependent and mediated through the loss of inhibitors of apoptosis proteins.
McEleny K; Coffey R; Morrissey C; Fitzpatrick JM; Watson RW
BJU Int; 2004 Aug; 94(3):402-6. PubMed ID: 15291876
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma.
Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Yeap BY; Sugarbaker DJ; Bueno R
J Pathol; 2007 Mar; 211(4):439-46. PubMed ID: 17253597
[TBL] [Abstract][Full Text] [Related]
15. Immunoexpression of inhibitors of apoptosis proteins and their antagonist SMAC/DIABLO in colorectal carcinoma: correlation with apoptotic index, cellular proliferation and prognosis.
De Oliveira Lima F; De Oliveira Costa H; Barrezueta LF; Fujiyama Oshima CT; Silva JA; Gomes TS; Pinheiro N; Neto RA; Franco M
Oncol Rep; 2009 Aug; 22(2):295-303. PubMed ID: 19578769
[TBL] [Abstract][Full Text] [Related]
16. The topoisomerase I inhibitor topotecan increases the sensitivity of prostate tumor cells to TRAIL/Apo-2L-induced apoptosis.
Griffith TS; Kemp TJ
Cancer Chemother Pharmacol; 2003 Sep; 52(3):175-84. PubMed ID: 12811515
[TBL] [Abstract][Full Text] [Related]
17. Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells.
Pennati M; Binda M; Colella G; Zoppe' M; Folini M; Vignati S; Valentini A; Citti L; De Cesare M; Pratesi G; Giacca M; Daidone MG; Zaffaroni N
Oncogene; 2004 Jan; 23(2):386-94. PubMed ID: 14724567
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.
Zhang M; Mukherjee N; Bermudez RS; Latham DE; Delaney MA; Zietman AL; Shipley WU; Chakravarti A
Prostate; 2005 Aug; 64(3):293-302. PubMed ID: 15754318
[TBL] [Abstract][Full Text] [Related]
19. Modulation of prostate carcinoma cell growth and apoptosis by chromogranin A.
Yu DS; Hsieh DS; Chang SY
J Urol; 2003 Nov; 170(5):2031-5. PubMed ID: 14532847
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]